CalciMedica, Inc. (CALC) insider trading

{
  "status": "OK",
  "results": [
    {
      "tickers": [
        "CALC"
      ],
      "issuer_cik": "0001534133",
      "owner_cik": "0001267959",
      "accession_number": "0001267959-26-000003",
      "form_type": "4",
      "filing_date": "2026-06-29",
      "period_of_report": "2026-06-25",
      "issuer_name": "CalciMedica, Inc.",
      "issuer_trading_symbol": "CALC",
      "owner_name": "Middleton Fred A",
      "is_director": true,
      "is_officer": false,
      "is_ten_percent_owner": true,
      "is_other": false,
      "security_type": "non_derivative",
      "record_type": "transaction",
      "security_title": "Common Stock",
      "transaction_timeliness": "O",
      "aff_10b5_one": false,
      "transaction_date": "2026-06-25",
      "transaction_code": "P",
      "equity_swap_involved": false,
      "transaction_shares": 248972,
      "transaction_price_per_share": 0.8033,
      "transaction_acquired_disposed": "A",
      "shares_owned_following_transaction": 1063272,
      "transaction_value": 199999.2076,
      "direct_or_indirect": "I",
      "nature_of_ownership": "By Sanderling Venture Partners VI Co-Investment Fund, L.P.",
      "footnotes": [
        {
          "id": "F1",
          "description": "The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated June 23, 2026, with a closing date of June 25, 2026. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors."
        },
        {
          "id": "F2",
          "description": "The Reporting Person, a director of Sanderling Ventures, may be deemed to beneficially own the securities of the Issuer held by Sanderling Venture Partners VI Co-Investment Fund, LP (\"SVP VI Co-Investment, LP\", together with Sanderling Venture Partners VI, LP., Sanderling VI Beteiligungs GmbH & Co. KG, Sanderling Ventures Management VI and Sanderling VI Limited Partnership (the \"Sanderling VI Securities\"). The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein."
        }
      ]
    }
  ]
}

// trimmed to 1 results

The response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.